Michael Hawkins (MD)

This article is a stub. You can help by expanding it.

Biographical Information

"Michael Hawkins, MD, a medical oncologist, is Medical Director of Smith Center and conducts clinical research in Oncology at Gilead Sciences in Foster City, CA. Formally, Dr. Hawkins was the Chief Medical Officer at Abraxis BioScience and was instrumental in obtaining FDA approval of Abraxane for women with metastatic breast cancer (2002-2007); an Associate Director of the Washington Cancer Institute at the Washington Hospital Center (1999-2002); the Director of the Clinical Research and Developmental Therapeutics Program at the Lombardi Cancer Center (1992-1999); and the Chief of the Investigational Drug Branch while at the National Cancer Institute (1984-1992). He was the chairman of the Cancer Advisory Panel to the NIH’s National Center for Complementary and Alternative Medicine from 2000-2002. In his oncology practice he encouraged patients to pursue inner healing while being treated for their cancer."

Affiliations

• Medical director, Smith Center for Healing and the Arts